Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)


    Role and Limitations of Lifestyle Modifications
    • Diet modifications, exercise, and weight loss (if appropriate) are recommended for patients with dyslipidemia
    • Other cardiovascular disease–associated risk factors should be addressed where present, eg, tobacco use, diabetes, and untreated renal disease
    • Pharmacologic interventions are recommended where dyslipidemia is unresponsive to lifestyle changes
    Treatment of Dyslipidemia With Statins

    Action required